Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2021-03-12 | Dan R. Littman, M.D., Ph.D. AGE: 68 DIRECTOR SINCE: 2018 BOARD COMMITTEES: Governance & Sustainability, Regulatory and Compliance and Science and Technology Helen L. and Martin S. Kimmel Professor of Molecular Immunology at the Skirball Institute of Biomolecular Medicine of NYU Langone Medical Center since 1995 and an Investigator, Howard Hughes Medical Institute, since 1987. Professor of Microbiology and Immunology at the University of California, San Francisco from 1985 to 1995. Member of the National Academy of the Sciences and the National Academy of Medicine. Fellow of the American Academy of Arts and Sciences and the American Academy of Microbiology. Founding Scientific Advisory Board Member of Vedanta Biosciences and Scientific co-founder and Advisory Board Member of Immunai, Inc. Member of Scientific Advisory Boards at ChemoCentryx, Inc., the Cancer Research Institute, the Broad Institute and the Ragon Institute of MGH, MIT and Harvard. Member of the Scientific Steering Committee of Parker Institute of Cancer Immunotherapy. Awarded the New York City Mayor’s Award for Excellence in Science and Technology (2004), the Ross Prize in Molecular Medicine (2013) and the Vilcek Prize in Biomedical Science (2016). KEY SKILLS & EXPERIENCE: Medicine & Science/Healthcare & Pharma/Academia: Dr. Littman’s background reflects significant achievements in medicine, healthcare and academia. He has served as a faculty member at the NYU Langone Medical Center for more than 25 years and is a renowned immunologist and molecular biologist. Pfizer benefits from his experience, expertise, achievements and recognition in both medicine and science. In addition, his experiences as a member of the National Academy of the Sciences and the National Academy of Medicine enable him to bring a broad perspective of the scientific and medical community to the Board. |
| 2022-03-17 | Director Nominees: Dan R. Littman, M.D., Ph.D. - Medicine & Science/Healthcare & Pharma. |
| 2023-03-16 | Dan R. Littman, M.D., Ph.D., Age: 70, Director Since: 2018, Board Committees: Governance & Sustainability, Regulatory and Compliance and Science and Technology, Total Compensation: $367,900 |
| 2024-03-14 | Dan R. Littman, M.D., Ph.D. Age: 71 Director Since: 2018 Board Committees: Governance & Sustainability, Regulatory and Compliance and Science and Technology 2023 Director Compensation Table: Fees Earned or Paid in Cash ($) 155,000, Stock Awards ($) 205,000, All Other Compensation ($) 31,400, Total ($) 391,400 |
Data sourced from SEC filings. Last updated: 2025-07-01